Creative Biolabs – Professional Service Provider of Oncolytic Virus Therapy Development

August 22 00:20 2020
As a leading services provider, Creative Biolabs has updated its first-class oncolytic virus therapy development services to support global scientists with their related programs.

New York, USA – August 21, 2020 – As a cancer treatment using a native or reprogrammed virus, oncolytic virotherapy has great potential in targeting and killing cancerous cells. Creative Biolabs has updated the oncolytic virus therapy development services, which show a higher level in customization, standardization and quality. The one-stop service covers the whole pipeline from virus engineering, cell biology to animal testing with a special emphasis on virus engineering and in vitro and in vivo validation.

• Oncolytic Virus Construction

With rich experience in immunology and oncology, Creative Biolabs has established a comprehensive platform called OncoVirapy™ for oncolytic virus construction services.

By virtue of OncoVirapy™, Creative Biolabs is able to generate the most efficacious oncolytic viral vector covering Adenovirus, Herpes Simplex Virus, Measles Virus, Vaccinia Virus, Vesicular Stomatitis Virus, and Adeno-Associated Virus, enabling wider applications in oncolytic virotherapy of cancers.

• Oncolytic Virus in vitro Validation Study

Creative Biolabs provides the state-of-art array of oncolytic virus in vitro validation study that is highly efficient in the virus functional activity test. The expert team at Creative Biolabs is skillful in plaque purification assay, identity assay, replication assay, tumor lytic assay, transgene expression assay, and transgene functional assay.

“We promise a precise report of all the in vitro assays by implementing standard process with the advancing platform. For example, our one-stop identity assays cover analysis of pathogenic genes, transgenes, viral specific genes or proteins, and for analyzing the transgene expression in recombinant oncolytic virus, we are experienced to use qPCR and western blotting to get the final result. We provide customized in vitro validation assays for clients’ specific oncolytic virus programs.” Introduced by a senior expert at Creative Biolabs.

• Oncolytic Virus in vivo Preclinical Study

Several in vivo preclinical assays has been developed at Creative Biolabs for different oncolytic virus development. Immuno-competent or immuno-compromised mouse models as well as non-human primate models can be used to validate the toxicity and efficacy for Investigational New Drug (IND) application.

In order to prove safety and efficacy of engineered oncolytic virus, the full range of in vivo preclinical studies services for engineered oncolytic virus at Creative Biolabs includes but is not limited to construction of xenograft/syngeneic animal models, immunogenicity tests, biodistribution/PK tests, oncolytic virus efficacy studies and toxicology studies.

In addition to these oncolytic virus development services, Creative Biolabs also offers various related products, such as oncolytic adenovirus construction kit including double-armed oncolytic adenovirus construction kit, etc., and pre-made oncolytic virus of reporter-encoding, cytokine-expressing, immune checkpoint antibody-armed, etc.

Detailed information about oncolytic virus-related services and products at Creative Biolabs can be found on

About Creative Biolabs

Empowered by leading technology and years of experience in biomedical science, Creative Biolabs has developed the OncoVirapy™ platform to support novel therapeutics development, providing comprehensive, end-to-end oncolytic virus therapy development services such as oncolytic virus engineering, construction, in vitro validation study, in vivo preclinical study, etc., as well as first-class products.

Media Contact
Company Name: Creative Biolabs
Contact Person: Bella Smith
Email: Send Email
Phone: 1-631-619-7922
Country: United States

view more articles

About Article Author